Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Fuentes

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 14, 2006
Thirteen week feeding study with transgenic maize grain containing event DAS-Ø15Ø7-1 in Sprague-Dawley ratsSusan A MacKenzie, Ian Lamb, Jean Schmidt, et al.
Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.
Journal of Medicinal Chemistry|March 18, 2005
Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Aihua Wang, Stuart Emanuel, et al.
Clinical Biochemistry|November 11, 2008
Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosisJudit García-Villoria, Aleix Navarro-Sastre, Carme Fons, et al.
Journal of Medicinal Chemistry|July 22, 2005
Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Catherine Prouty, Aihua Wang, et al.
Molecular Pharmacology|November 3, 2007
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumorsStuart L Emanuel, Terry V Hughes, Mary Adams, et al.
Molecular Pharmacology|August 24, 2004
A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft modelsStuart Emanuel, Robert H Gruninger, Angel Fuentes-Pesquera, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 14, 2006
Thirteen week feeding study with transgenic maize grain containing event DAS-Ø15Ø7-1 in Sprague-Dawley ratsSusan A MacKenzie, Ian Lamb, Jean Schmidt, et al.
Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.
Journal of Medicinal Chemistry|March 18, 2005
Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Aihua Wang, Stuart Emanuel, et al.
Clinical Biochemistry|November 11, 2008
Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosisJudit García-Villoria, Aleix Navarro-Sastre, Carme Fons, et al.
Journal of Medicinal Chemistry|July 22, 2005
Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Catherine Prouty, Aihua Wang, et al.
Molecular Pharmacology|November 3, 2007
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumorsStuart L Emanuel, Terry V Hughes, Mary Adams, et al.
Molecular Pharmacology|August 24, 2004
A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft modelsStuart Emanuel, Robert H Gruninger, Angel Fuentes-Pesquera, et al.
Pageof 2